CA2315066A1 - Procede de preparation d'hydrochlorure de paroxetine - Google Patents

Procede de preparation d'hydrochlorure de paroxetine Download PDF

Info

Publication number
CA2315066A1
CA2315066A1 CA002315066A CA2315066A CA2315066A1 CA 2315066 A1 CA2315066 A1 CA 2315066A1 CA 002315066 A CA002315066 A CA 002315066A CA 2315066 A CA2315066 A CA 2315066A CA 2315066 A1 CA2315066 A1 CA 2315066A1
Authority
CA
Canada
Prior art keywords
paroxetine hydrochloride
propan
solvate
preparation
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002315066A
Other languages
English (en)
Inventor
David Alan Jones
Neal Ward
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2315066A1 publication Critical patent/CA2315066A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Cette invention concerne un procédé de préparation d'un solvat propan-2-ol d'hydrochlorure de paroxetine, lequel consiste à former une solution d'hydrochlorure de paroxetine dans un mélange comprenant du propan-2-ol et un co-solvant efficace. Le solvat propan-2-ol d'hydrochlorure de paroxetine est ensuite cristallisé à partir de cette solution.
CA002315066A 1997-12-19 1998-12-18 Procede de preparation d'hydrochlorure de paroxetine Abandoned CA2315066A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9726907.0 1997-12-19
GBGB9726907.0A GB9726907D0 (en) 1997-12-19 1997-12-19 Novel compounds
PCT/GB1998/003836 WO1999032484A1 (fr) 1997-12-19 1998-12-18 Procede de preparation d'hydrochlorure de paroxetine

Publications (1)

Publication Number Publication Date
CA2315066A1 true CA2315066A1 (fr) 1999-07-01

Family

ID=10823933

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002315066A Abandoned CA2315066A1 (fr) 1997-12-19 1998-12-18 Procede de preparation d'hydrochlorure de paroxetine

Country Status (20)

Country Link
EP (1) EP1042318A1 (fr)
JP (1) JP2001526288A (fr)
KR (1) KR20010033317A (fr)
CN (1) CN1281448A (fr)
AP (1) AP2000001836A0 (fr)
AU (1) AU1769899A (fr)
BG (1) BG104604A (fr)
BR (1) BR9813638A (fr)
CA (1) CA2315066A1 (fr)
EA (1) EA200000689A1 (fr)
GB (1) GB9726907D0 (fr)
HU (1) HUP0004503A3 (fr)
ID (1) ID24733A (fr)
IL (1) IL136590A0 (fr)
NO (1) NO20003145D0 (fr)
OA (1) OA11635A (fr)
PL (1) PL341358A1 (fr)
SK (1) SK9242000A3 (fr)
TR (1) TR200001933T2 (fr)
WO (1) WO1999032484A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9919001D0 (en) * 1999-08-12 1999-10-13 Smithkline Beecham Plc Novel process
GB9923439D0 (en) * 1999-10-04 1999-12-08 Smithkline Beecham Plc Novel process
NL1017421C2 (nl) 2001-02-21 2002-01-15 Synthon Bv Werkwijze voor het vervaardigen van paroxetine.
JP2005524656A (ja) * 2002-02-22 2005-08-18 テバ ファーマシューティカル インダストリーズ リミティド 新規中間物質を用いるパロキセチンの調製
KR100672184B1 (ko) 2004-09-21 2007-01-19 주식회사종근당 파록세틴의 콜린산 또는 콜린산 유도체 염

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0223403B1 (fr) * 1985-10-25 1993-08-04 Beecham Group Plc Dérivé de pipéridine, sa préparation et son utilisation comme médicament
SK283608B6 (sk) * 1995-02-06 2003-10-07 Smithkline Beecham Plc Bezvodý hydrochlorid paroxetínu, spôsob jeho výroby a použitie
CA2187128A1 (fr) * 1996-10-04 1997-06-26 K. S. Keshava Murthy Polymorphe nouveau et efficace, a base de chlorhydrate de paroxetine anhydre

Also Published As

Publication number Publication date
OA11635A (en) 2004-11-22
BR9813638A (pt) 2000-10-17
AP2000001836A0 (en) 2000-06-30
TR200001933T2 (tr) 2000-12-21
HUP0004503A3 (en) 2002-04-29
NO20003145L (no) 2000-06-16
AU1769899A (en) 1999-07-12
EP1042318A1 (fr) 2000-10-11
EA200000689A1 (ru) 2000-12-25
ID24733A (id) 2000-08-03
SK9242000A3 (en) 2001-01-18
KR20010033317A (ko) 2001-04-25
PL341358A1 (en) 2001-04-09
BG104604A (en) 2001-03-30
IL136590A0 (en) 2001-06-14
NO20003145D0 (no) 2000-06-16
JP2001526288A (ja) 2001-12-18
CN1281448A (zh) 2001-01-24
HUP0004503A2 (hu) 2002-03-28
GB9726907D0 (en) 1998-02-18
WO1999032484A1 (fr) 1999-07-01

Similar Documents

Publication Publication Date Title
CA2315066A1 (fr) Procede de preparation d'hydrochlorure de paroxetine
MXPA00006040A (en) Process for the preparation of paroxetine hydrochloride
WO2000032593A1 (fr) Procede de fabrication d'hydrochlorure de paroxetine
EP1187830A1 (fr) Procede de preparation de paroxetine et composes structurellement apparentes
CZ20002256A3 (cs) Způsob přípravy paroxetinhydrochloridu
CA2323896A1 (fr) Forme cristalline de la paroxetine
AU5428999A (en) Process for the preparation of a non-crystalline anhydrate form of paroxetine hydrochloride
EP1135383B1 (fr) Solvates de paroxetine propan-2-ol melanges
EP1242378A1 (fr) Nouveaux procedes
US20010008940A1 (en) Novel process
WO2000032595A1 (fr) Processus de production de solvate acetonique d'hydrochlorure de paroxetine
WO2001012623A1 (fr) Procede de preparation d'hydrochlorure de paroxetine anhydre
US20020028942A1 (en) Novel process and compound
EP1140910A1 (fr) Procede de preparation d'un acetate de paroxetine ou d'analogues de paroxetine
WO2001014335A1 (fr) Procede de preparation d'un intermediaire de paroxetine
WO2000039122A1 (fr) Procede de preparation d'un acetate de paroxetine et de ses analogues
EP1140912A1 (fr) Procede de preparation d'un sel d'acetate de paroxetine ou d'analogues de paroxetine
WO2000032592A1 (fr) Procede de fabrication d'hydrochlorure de paroxetine
CZ20003343A3 (cs) Krystalická forma paroxetinu
WO2001025201A1 (fr) Procede de preparation de produit intermediaire de paroxetine
WO2001017966A1 (fr) Procede de preparation de 1-methyl-3-carbomethoxy-4-(4'-fluorophenyl)-piperidine
WO2001029002A1 (fr) Preparation d'esters de 4-(fluorophenyl)piperidine
MXPA00009137A (es) Forma cristalina de paroxetina

Legal Events

Date Code Title Description
FZDE Discontinued